Gail E. Sonenshein
Affiliations: | Boston University, Boston, MA, United States |
Area:
Molecular Biology, BiochemistryWebsite:
https://facultyprofiles.tufts.edu/gail-sonensheinGoogle:
"Gail Sonenshein"Bio:
https://books.google.com/books?id=ij_gAAAAMAAJ
DOI: 10.1016/0006-291X(68)90578-0
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Charles E. Holt | grad student | 1970 | MIT (DevTree) | |
| (Studies on the Satellite DNA's of Physarum Polycephalum) | ||||
Children
Sign in to add trainee| Mary A. Stepp | grad student | 1986 | Boston University (E-Tree) |
| William C. Yang | grad student | 2000 | Boston University |
| Kathryn T. Kavanagh | grad student | 2002 | Boston University |
| Claudia S. Hofmann | grad student | 2003 | Boston University |
| Elizabeth G. Demicco | grad student | 2005 | Boston University |
| Shangquin Guo | grad student | 2005 | Boston University |
| Vidyalakshmi Chandramohan | grad student | 2006 | Boston University |
| Xiaobo Wang | grad student | 2007 | Boston University |
| Nora Mineva | grad student | 2008 | Boston University |
| Chengyin Min | grad student | 2009 | Boston University |
| Junfeng Wu | grad student | 2010 | Boston University |
| Ziyang Yu | grad student | 2011 | Boston University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pianetti S, Miller KD, Chen HH, et al. (2023) ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients. Cancer Cell International. 23: 165 |
| de la Cueva A, Emmerling M, Lim SL, et al. (2018) A Polymorphism in the Lysyl Oxidase Propeptide Domain Accelerates Carcinogen-induced Cancer. Carcinogenesis |
| Sánchez-Morgan N, Kirsch KH, Trackman PC, et al. (2017) UXT is a LOX-PP Interacting Protein that Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells. Journal of Cellular Biochemistry |
| Das SG, Pianetti S, Sonenshein GE, et al. (2017) Abstract 23: Antibody targeting of ADAM8 for treatment of triple-negative breast cancer Cancer Research. 77: 23-23 |
| Romagnoli M, Pianetti S, Das SG, et al. (2017) Abstract 1137: ADAM8 drives aggressive phenotype of triple-negative inflammatory breast cancer & constitutes a novel therapeutic target Cancer Research. 77: 1137-1137 |
| Lyons J, Polmear M, Mineva ND, et al. (2016) Endogenous light scattering as an optical signature of circulating tumor cell clusters. Biomedical Optics Express. 7: 1042-50 |
| Das SG, Romagnoli M, Mineva ND, et al. (2016) miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells. Breast Cancer Research : Bcr. 18: 40 |
| Srinivasan S, Romagnoli M, Bohm A, et al. (2014) N-glycosylation regulates ADAM8 processing and activation. The Journal of Biological Chemistry. 289: 33676-88 |
| Romagnoli M, Mineva ND, Polmear M, et al. (2014) ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. Embo Molecular Medicine. 6: 278-94 |
| Bais MV, Ozdener GB, Sonenshein GE, et al. (2014) Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways Oncogene. 34: 1928-1937 |